OFI Advisors’s Integra LifeSciences IART Stock Holding History

OFI Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$481K	Sell	16,150 -3,933	-20%	-$123K	0.03%	720
2015 Q2	$553K	Sell	20,083 -940	-4%	-$25.1K	0.03%	677
2015 Q1	$530K	Buy	21,023 +661	+3%	+$15.6K	0.03%	696
2014 Q4	$451K	Buy	20,362 +665	+3%	+$13.5K	0.03%	739
2014 Q3	$400K	Sell	19,697 -802	-4%	-$16K	0.03%	758
2014 Q2	$394K	Buy	20,499 +1,876	+10%	+$35K	0.03%	784
2014 Q1	$350K	Buy	18,623 +637	+4%	+$12.3K	0.03%	797
2013 Q4	$351K	Buy	17,986 +1,113	+7%	+$20.4K	0.03%	751
2013 Q3	$278K	Buy	16,873 +1,548	+10%	+$24.8K	0.03%	770
2013 Q2	$229K	Buy	+15,325	New	+$225K	0.02%	801

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OFI Advisors's IART Position: Q3 2015 in Review

OFI Advisors reduced its Integra LifeSciences (IART) stake by 20% in Q3 2015, selling an estimated $123K and leaving 16,150 shares worth $481K. The position accounts for 0.03% of the portfolio, ranked #720.

OFI Advisors first reported a position in IART in Q2 2013 and has held it in 10 quarters since. The position peaked at $553K in Q2 2015. 189 funds tracked by Wall St. Rank hold IART as of Q3 2015.

OFI Advisors held 16,150 shares of Integra LifeSciences worth $481K as of Q3 2015.
OFI Advisors sold 3,933 Integra LifeSciences shares in Q3 2015, an estimated $123K.
Integra LifeSciences made up 0.03% of OFI Advisors's portfolio in Q3 2015, its #720 holding.
OFI Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Integra LifeSciences position peaked at $553K in Q2 2015.
189 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.